Literature DB >> 30075341

Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.

Mirna Chehade1, Stacie M Jones2, Robbie D Pesek2, A Wesley Burks3, Brian P Vickery3, Robert A Wood4, Donald Y M Leung5, Glenn T Furuta6, David M Fleischer6, Alice K Henning7, Peter Dawson7, Robert W Lindblad7, Scott H Sicherer8, J Pablo Abonia9, Joseph D Sherrill9, Hugh A Sampson8, Marc E Rothenberg9.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EoE) is increasingly common, but data on phenotypic aspects are still incomplete.
OBJECTIVES: To describe the clinical, endoscopic, and histopathologic features of a large number of children and adults with EoE across the United States.
METHODS: This was a multisite single visit registry enrolling subjects aged 6 months to 65 years with EoE. Participants provided responses regarding their medical history, with verification of the diagnosis and history by the study teams.
RESULTS: A total of 705 subjects were analyzed (median [interquartile range] age at enrollment 11.2 [6.7-17.7] years, 68.2% male, 87.9% whites). Of these, 67 subjects had concurrent gastrointestinal eosinophilia, with gastric mucosa most common. An age- and race-dependent time gap was present between symptom onset and time of diagnosis (adults and whites with longer gap). Food allergy and atopic dermatitis were associated with a decrease in this gap. Symptoms varied with age (more dysphagia and food impaction in adults) and with race (more vomiting in non-whites). Esophageal rings and strictures at diagnosis were more common in adults, although esophageal eosinophilia was comparable among age groups. Concomitant allergic disease (91%), infectious/immunologic disorders (44%), neurodevelopmental disorders (30%), and failure to thrive (21%) were common. Depression/anxiety increased with age. EoE was reported in 3% of parents and 4.5% of siblings.
CONCLUSIONS: Gastrointestinal eosinophilia is present in approximately 10% of patients with EoE; the symptom-diagnosis time gap is influenced by age, race, food allergy, and atopic dermatitis; symptoms vary with race; concurrent infectious/immunologic disorders and mental health disorders are common; and the level of esophageal eosinophils is comparable in patients with and without fibrostenotic features.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopy; Autoimmune disease; Eosinophilic colitis; Eosinophilic esophagitis; Eosinophilic gastritis; Eosinophilic gastroenteritis; Food allergy; Multisite; Proton pump inhibitor; Race; Registry

Mesh:

Year:  2018        PMID: 30075341      PMCID: PMC6132253          DOI: 10.1016/j.jaip.2018.05.038

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  38 in total

1.  Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis.

Authors:  Alfredo J Lucendo; Ángel Arias; Jesús González-Cervera; José María Olalla; Javier Molina-Infante
Journal:  J Allergy Clin Immunol       Date:  2015-09-12       Impact factor: 10.793

2.  Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis.

Authors:  Jamie Sodikoff; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2015-08-25       Impact factor: 10.793

3.  Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.

Authors:  Manish Arora; Preet Bagi; Anna Strongin; Jennifer Heimall; Xiongce Zhao; Monica G Lawrence; Apurva Trivedi; Carolyn Henderson; Amy Hsu; Martha Quezado; David E Kleiner; Aradhana M Venkatesan; Steven M Holland; Alexandra F Freeman; Theo Heller
Journal:  J Clin Immunol       Date:  2017-08-13       Impact factor: 8.317

4.  Eosinophilic esophagitis diagnosed in a patient with common variable immunodeficiency.

Authors:  Meng Chen; Huaibin M Ko; Mary E Riffle; Doerthe A Andreae; Charlotte Cunningham-Rundles; Mirna Chehade; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016-05-04

Review 5.  Systematic review: the association between eosinophilic oesophagitis and coeliac disease.

Authors:  A J Lucendo; Á Arias; J M Tenias
Journal:  Aliment Pharmacol Ther       Date:  2014-07-04       Impact factor: 8.171

Review 6.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

7.  Esophageal subepithelial fibrosis in children with eosinophilic esophagitis.

Authors:  Mirna Chehade; Hugh A Sampson; Raffaella A Morotti; Margret S Magid
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-09       Impact factor: 2.839

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

9.  Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Authors:  Alain M Schoepfer; Alex Straumann; Radoslaw Panczak; Michael Coslovsky; Claudia E Kuehni; Elisabeth Maurer; Nadine A Haas; Yvonne Romero; Ikuo Hirano; Jeffrey A Alexander; Nirmala Gonsalves; Glenn T Furuta; Evan S Dellon; John Leung; Margaret H Collins; Christian Bussmann; Peter Netzer; Sandeep K Gupta; Seema S Aceves; Mirna Chehade; Fouad J Moawad; Felicity T Enders; Kathleen J Yost; Tiffany H Taft; Emily Kern; Marcel Zwahlen; Ekaterina Safroneeva
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

10.  Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study.

Authors:  Kathryn Peterson; Rafael Firszt; John Fang; Jathine Wong; Ken R Smith; Kristina A Brady
Journal:  Am J Gastroenterol       Date:  2016-05-24       Impact factor: 10.864

View more
  22 in total

Review 1.  Feeding difficulties in children with non-IgE-mediated food allergic gastrointestinal disorders.

Authors:  Mirna Chehade; Rosan Meyer; Alexia Beauregard
Journal:  Ann Allergy Asthma Immunol       Date:  2019-03-26       Impact factor: 6.347

Review 2.  Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.

Authors:  Ian F Slack; Justin T Schwartz; Vincent A Mukkada; Shawna Hottinger; J Pablo Abonia
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-06       Impact factor: 4.806

Review 3.  Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.

Authors:  Dilawar Khokhar; Sahiti Marella; Gila Idelman; Joy W Chang; Mirna Chehade; Simon P Hogan
Journal:  Clin Exp Allergy       Date:  2022-07-19       Impact factor: 5.401

4.  British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Authors:  Anjan Dhar; Hasan N Haboubi; Stephen E Attwood; Marcus K H Auth; Jason M Dunn; Rami Sweis; Danielle Morris; Jenny Epstein; Marco R Novelli; Hannah Hunter; Amanda Cordell; Sharon Hall; Jamal O Hayat; Kapil Kapur; Andrew Robert Moore; Carol Read; Sarmed S Sami; Paul J Turner; Nigel J Trudgill
Journal:  Gut       Date:  2022-05-23       Impact factor: 31.793

Review 5.  One march, many paths: Insights into allergic march trajectories.

Authors:  Stanislaw J Gabryszewski; David A Hill
Journal:  Ann Allergy Asthma Immunol       Date:  2021-05-07       Impact factor: 6.248

6.  Medication Adherence Aligns with Age and a Behavioral Checklist but Not Symptoms or Quality of Life for Patients with Eosinophilic Esophagitis.

Authors:  Pooja Mehta; Zhaoxing Pan; Stephanie Skirka; Bethany M Kwan; Calies Menard-Katcher
Journal:  J Pediatr       Date:  2021-04-01       Impact factor: 6.314

7.  Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes.

Authors:  Leah C Kottyan; Michael P Trimarchi; Xiaoming Lu; Julie M Caldwell; Avery Maddox; Sreeja Parameswaran; Michael Lape; Rahul J D'Mello; Madeline Bonfield; Adina Ballaban; Vincent Mukkada; Philip E Putnam; Pablo Abonia; Netali Ben-Baruch Morgenstern; Amy A Eapen; Ting Wen; Matthew T Weirauch; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2020-10-23       Impact factor: 14.290

8.  High prevalence of developmental disorders in pediatric eosinophilic esophagitis (EoE): A single-center observational study.

Authors:  Julia K Sohn; Barrett H Barnes; Amani Al-Hazaymeh; Bryan G Sauer; Emily C McGowan
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10-01

Review 9.  Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach.

Authors:  Pierfrancesco Visaggi; Lucia Mariani; Veronica Pardi; Emma Maria Rosi; Camilla Pugno; Massimo Bellini; Fabiana Zingone; Matteo Ghisa; Elisa Marabotto; Edoardo G Giannini; Vincenzo Savarino; Santino Marchi; Edoardo V Savarino; Nicola de Bortoli
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

10.  Psychiatric Comorbidities and Psychiatric Medication Use Are Highly Prevalent in Patients With Eosinophilic Esophagitis and Associate With Clinical Presentation.

Authors:  Craig C Reed; S Ryanne Corder; Erin Kim; Emily Sanders; Manaswita Tappata; Swathi Eluri; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.